Code

Data Science in Medicine: 5 Ways to Develop New Drugs

Data Science in Medicine: 5 Ways to Develop New Drugs

Python course: 4 projects for beginners and experienced Coders

Learn more

The Need for New Drugs

Modern medicine requires the constant introduction of innovative drugs. Scientists around the world are actively developing and testing new drugs, and this is not associated with any conspirators in the pharmaceutical industry. Outdated drugs can lose their effectiveness due to the development of microbial resistance or changes in disease mechanisms. In this regard, the search for and creation of new drugs is becoming a priority for medicine. Innovative drugs can improve the treatment of various diseases, improve the quality of life of patients and reduce the risk of complications. The development of new drugs is a key aspect ensuring progress in healthcare and the development of effective therapy.

Antibiotics are a classic example of drugs that have saved millions of lives. However, the microorganisms they affect are able to adapt and develop resistance to these drugs. This process raises serious public health concerns, as resistant infections can lead to treatment complications and an increase in the number of cases. The problem of antibiotic resistance requires careful attention and active measures to control and prevent the further spread of resistant strains.

From the 1980s to 2020, the scientific community failed to develop a single new class of antibiotics, despite intensive research in this area. This is a serious concern, as the lack of new effective drugs could leave humanity vulnerable to bacterial infections. The situation requires particular attention, as antibiotic-resistant microbiota continues to pose a growing threat to public health. Innovative approaches to the development of antibacterial agents are needed to ensure effective treatment and prevent the spread of resistant strains.

Modern technologies, including artificial intelligence, play an important role in solving pressing problems in medicine. In 2020, researchers from the Massachusetts Institute of Technology presented results that offer hope for the future. Using neural networks, they identified a new antibacterial compound that could significantly impact the fight against infections and antibiotic resistance. This discovery highlights the potential for using this technology in medical research and drug development. The new compound, named halicin, is named after the famous supercomputer HAL 9000 from the film 2001: A Space Odyssey. Preliminary tests on laboratory mice showed that halicin is highly effective against bacteria that have developed resistance to standard antibiotics. This discovery could be a significant step in the development of new treatments for infectious diseases and the fight against antibiotic resistance.

Still: film "2001: A Space Odyssey"

Chalicin has a unique mechanism of action, which significantly complicates the development of resistance in pathogenic bacteria. This discovery gives hope that this compound will be able to maintain its effectiveness in the treatment of various bacterial infections over a long period of time. The use of halicin in medicine may be an important step in the fight against antibiotic resistance and improve the results of treatment of bacterial diseases.

In silico methods in drug development

Modern pharmaceuticals actively use computer technologies for the development of new drugs, known as in silico, which translates as "in silicon". This term has become an alternative to traditional in vitro (test tube) and in vivo (in a living organism) methods, emphasizing the importance of computational methods in scientific research. The use of in silico approaches allows us to accelerate the process of searching for and testing new drugs, reducing costs and increasing the efficiency of development. As a result, computer technologies are becoming an integral part of pharmaceutical science, opening new horizons for innovative solutions in the treatment of various diseases.

Previously, research into potential drugs was conducted exclusively in the laboratory or on animals. Currently, scientists use computers with high-performance silicon processors to model and analyze molecules. This significantly accelerates the drug development process and improves its effectiveness. The use of computer modeling in pharmaceuticals opens new horizons for the development of innovative drugs, which in turn contributes to improved treatments for various diseases.

There are two main approaches to in silico methods for discovering new pharmaceutical compounds. The first approach is rational drug design, which is based on the use of computer models to predict interactions between molecules. This method allows for the study of the structure and properties of potential compounds, significantly accelerating the development of new drugs. The second approach involves virtual screening of libraries of chemical compounds to identify those with the desired biological activity. This method allows for the rapid analysis of large volumes of data and the identification of candidates for further testing. Both approaches are important tools for modern pharmaceutical research and help optimize the drug discovery process.

  • Repurposing: This method allows for the identification of effective active substances among millions of existing molecules that may have previously been underestimated.
  • Modeling of new compounds: This is the most complex and expensive process, requiring not only computer modeling but also subsequent synthesis of the molecule. At this stage, there is a risk that the new drug may be unsuitable for mass production or cause unexpected side effects.

One successful example of drug repurposing is the creation of halicin. This compound, based on the SU-3327 molecule, was synthesized over ten years ago to treat diabetes. However, due to its low efficacy, the research was discontinued. However, in recent years, chalicin has attracted the attention of scientists due to its potential antibacterial properties, highlighting the importance of repurposing existing drugs to find new therapeutic solutions. The SU-3327 molecule had long been sitting in pharmaceutical company databases without active use. In 2020, a group of American scientists, using artificial intelligence technologies, discovered its potential and adapted it to create a new antibiotic, named chalicin. This medical breakthrough opens new horizons in the fight against infectious diseases and highlights the importance of using innovative technologies to develop effective drugs.

Chalicin molecules (top). Photo: Massachusetts Institute of Technology

Discovery of Halicin: A New Antibiotic Among Millions of Molecules

Scientists, in an effort to find effective antibiotics, have used modern data analysis technologies such as neural networks. These advanced models, capable of mimicking the human brain, adapt and learn from existing data. The use of neural networks in this field opens up new possibilities for antibiotic development, allowing for more accurate predictions of their effectiveness and minimizing the time it takes to discover new drugs.

Researchers at the Massachusetts Institute of Technology (MIT) developed a neural network that was trained on 2,400 records of substances with known antibacterial properties. This training set included both officially approved drugs and natural compounds of plant and animal origin. This work aims to discover new antibacterial agents and could significantly accelerate the development of effective drugs to combat infections.

To efficiently process information, the neural network uses a special algorithm to convert antibiotic molecules into numerical formats. This process allows the system to analyze large volumes of data and identify potential candidates for further research. The use of numerical formats significantly improves the accuracy and speed of analysis, which is an important step in the development of new antibiotics.

After completing training, the neural network was loaded with a database of 6,100 records of molecules for which there was previously no information on their antibiotic properties. In addition, the researchers used another extensive database with 107 million records. Artificial intelligence analyzed this information and identified several dozen promising molecules with potential antibiotic properties.

The selected molecules were passed on for analysis to a second neural network designed to predict the toxicity of substances. This algorithm was developed using ClinTox data from the American Academy of Clinical Toxicology, which includes information on adverse events for both approved drugs and those that have failed clinical trials. Using this neural network improves the accuracy of toxicity predictions and improves the process of developing safe drugs.

In the final stage of analysis, candidate molecules were algorithmically evaluated to determine their similarity to known antibiotics. The researchers' goal was to eliminate traditional analogs of existing drugs and identify a new class of antibiotics capable of effectively combating bacteria resistant to existing therapies. This discovery could play a key role in the fight against infections caused by resistant pathogens and significantly expand the arsenal of antibacterial drugs.

The analysis identified nine promising compounds, among which a molecule named SU-3327 stands out. In vitro tests on mice showed impressive efficacy in healing wounds infected with bacteria resistant to traditional antibiotics. These results open new horizons in the development of drugs for the treatment of complex infections and highlight the potential of SU-3327 as a promising tool in the fight against antibiotic resistance.

Inspired by these advances, the scientific team renamed SU-3327 "halicin" and published their research results in a peer-reviewed scientific journal. This discovery offers hope for the development of new antibiotics capable of effectively combating drug-resistant infections. Research in this area is important for medicine, as new antibiotics can significantly improve the treatment of infectious diseases and reduce the risks associated with antibiotic resistance.

Photo: National Cancer Institute / Unsplash

Innovations in Machine Learning Clinics

Founded in 2018, the MIT Machine Learning Clinic is a leading center for research focused on transforming healthcare using artificial intelligence. The clinic's primary goal is to revolutionize the prevention, detection, and treatment of diseases. Through cutting-edge technologies and innovative approaches, the clinic strives to improve the quality of healthcare services and make them more accessible to patients. Research conducted at the clinic focuses on the development and implementation of machine learning algorithms that can significantly improve the accuracy of diagnosis and the effectiveness of treatment for various diseases.

Modern machine learning research requires the integration of expert knowledge from various disciplines, such as microbiology, chemistry, pharmaceuticals, and medicine. Successful implementation of this research requires not only powerful computing resources but also well-equipped laboratories. The availability of experimental animals and qualified medical personnel capable of ensuring high standards of safety and ethics in scientific experiments is also essential. The synergy between these areas facilitates a deeper understanding of processes and enables the creation of innovative solutions in healthcare and other industries.

The clinic is proud of its significant achievement – ​​the discovery of halicin, which was a key step in the field of medicine. However, this is only part of the extensive scientific work carried out at the institution. The clinic's research projects include many relevant areas, among which the early detection of diseases stands out. This area is key to increasing the effectiveness of treatment and improving the quality of life of patients.

The clinic's specialists developed innovative algorithms that formed the basis of clinical trials of a foreign vaccine against COVID-19. These technologies significantly simplified the process of identifying target populations and geographic regions for testing and also provided a comprehensive assessment of the vaccine's effectiveness. The implementation of such algorithms contributes to the quality of clinical trials and accelerates the development of effective vaccines.

The creation of a model for the early detection of signs of Alzheimer's disease using deep machine learning methods has become a significant achievement in the field of medicine. This breakthrough in diagnostics could revolutionize the treatment and prevention of neurological diseases by providing earlier and more accurate diagnosis of patients' conditions. Using modern technologies and machine learning algorithms can improve diagnostic efficiency and the quality of life of people suffering from this disease.

Innovative Developments in Medicine

Modern in silico research is attracting the attention of scientists around the world, including experts from the Massachusetts Institute of Technology and many other scientific organizations. This field of science is actively developing and encompasses various aspects, such as modeling biological processes and big data analysis. In silico research is becoming an important tool for predicting experimental results and accelerating scientific discoveries, making it an integral part of the modern scientific process.

Japan is actively advancing in the field of medical drug development using neural networks. Japanese scientists have created the drug DSP-1181, which promises significant assistance in the treatment of mental illnesses. Remarkably, the entire development process took just 12 months, significantly faster than traditional timelines for similar projects. This achievement highlights the potential of artificial intelligence in pharmaceuticals and opens new horizons for the rapid development of effective drugs.

In Italy, scientists used computer modeling to develop a vaccine designed to protect children from bacterial meningitis. This study highlights the importance of modern technologies in medical research and their role in creating effective vaccines. The use of computer modeling can accelerate the development process and improve vaccine safety, which is especially important for protecting vulnerable populations such as children.

Hong Kong-based startup Insilico Medicine, founded by AI expert Alexander Zhavoronkov, has achieved significant advances in drug development. In 2019, the company created a new drug for the treatment of fibrosis in just three weeks using artificial neural network technology. This approach significantly accelerates the development process compared to traditional methods, which typically take years. AI innovations used by Insilico Medicine are opening new horizons in the pharmaceutical industry and have the potential to revolutionize the approach to creating effective drugs.

Insilico Medicine has achieved significant results published in scientific journals, recognizing their contribution to the development of medicine and biotechnology. The neural network model code is available on GitHub, ensuring transparency and the ability for researchers and developers to use and adapt these achievements to their needs. Open data facilitates further study and the implementation of innovative technologies in medical practice.

Research in medicine and pharmacology is actively conducted in Russia. This important topic was discussed at a recent meeting attended by the Russian president. In 2014, scientists from the Higher School of Economics and the Zelinsky Institute of Organic Chemistry of the Russian Academy of Sciences developed an in silico model of a leukemia drug. In 2017, they created a drug for the treatment of rheumatoid arthritis. In 2020, researchers made a significant discovery, identifying a molecule that could help fight cancer. These achievements underscore the importance of scientific research in Russia and its contribution to the development of effective treatments for serious diseases.

In 2020, a joint study by scientists from Skoltech, Moscow State University, and the Institute of Evolutionary Physics and Biochemistry of the Russian Academy of Sciences was completed using the Zhores supercomputer. The study included molecular modeling of a drug for the treatment of depression. The team is currently preparing for animal trials. This is a significant step in the development of effective treatments for depression, which could lead to the creation of innovative drugs and improved quality of life for patients.

COVID-19: Prevention as the Key to Fighting the Pandemic

The scientific community is actively working to develop effective drugs against COVID-19, using modern technologies, including computer modeling. These studies are aimed at identifying promising drugs that can significantly improve the fight against the virus. The use of computer modeling helps accelerate the development and testing of new medications, which is critical during a pandemic. These efforts are resulting in innovative solutions that can significantly improve the effectiveness of COVID-19 treatment and improve public health.

Russian virology scientists have successfully developed two drugs that they believe can effectively target the virus. Meanwhile, foreign researchers discovered four substances with similar properties in their 2020 study. These discoveries open new horizons for the fight against viral infections and highlight the importance of international collaboration in scientific research.

Despite the promising prospects, it is important to recognize that modeling is not a final solution. Experimental studies are necessary to confirm the effectiveness of the obtained results. Currently, several compounds modeled in silico are available that are theoretically capable of destroying the coronavirus. However, clinical trials of these compounds require significant time to obtain reliable data.

Creating a universal drug for COVID-19 remains an urgent task. While vaccination and preventive measures recommended by the World Health Organization (WHO), such as social distancing and wearing masks, remain the most effective methods for containing the spread of the virus, the scientific community is actively working to develop new therapeutics. These efforts are aimed at improving public health and reducing the risk of infection, which emphasizes the importance of a comprehensive approach to combating the pandemic.

Fighting the pandemic requires a comprehensive approach and regular knowledge updates. It's important to stay informed about the latest research and recommendations from reputable organizations like the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). Relying on reliable sources of information will help you make informed decisions and follow current precautions. Remember that your safety and the health of others depend on being aware of and following recommendations, so it is important to monitor the evolving situation and adapt to new challenges.

Read also:

  • Killing the Matrix in the Bud: 7 Arguments for Arguing with an AI Fan
  • Can Robots Love, Write Laws, and Dream?
  • How to Start Programming in Python

Python Developer: 3 Projects for a Successful Career

Want to become a Python developer? Find out how 3 projects and expert help will help you with this!

Find out more